Intravenous fluid exemption cannot be narrowed retrospectively; qualifying sterile large-volume preparations remain exempt despite medicinal additives.
Intravenous fluids covered by Notification No. 6/2000-C.E., as amended, remained exempt where they were sterile large-volume preparations cleared for intravenous use, and the later Notification No. 3/2001-C.E. could not retrospectively narrow that earlier exemption. Products of 100 ml or more with medicinal additives were treated as intravenous fluids, while smaller-volume preparations and goods for peritoneal dialysis or irrigation fell outside the exemption. Duty was sustained only for the non-qualifying goods, but penalty under Section 11AC and Rule 173Q and interest under Section 11AB were not justified because the dispute was interpretational and the relevant facts were disclosed. Cum-duty benefit was directed in recomputation.
Issues: (i) Whether the assessees' products cleared as intravenous fluids were entitled to exemption under Notification No. 6/2000-C.E. as amended by Notification No. 36/2000-C.E., and whether the later Notification No. 3/2001-C.E. could be used to narrow the scope of the earlier exemption; (ii) Whether duty demand, penalty and interest were sustainable in respect of the goods found outside the exempted category.
Issue (i): Whether the assessees' products cleared as intravenous fluids were entitled to exemption under Notification No. 6/2000-C.E. as amended by Notification No. 36/2000-C.E., and whether the later Notification No. 3/2001-C.E. could be used to narrow the scope of the earlier exemption.
Analysis: The exemption under Notification No. 6/2000-C.E. covered intravenous fluids under Chapter 30, and the subsequent Notification No. 3/2001-C.E. was treated as an independent notification rather than an interpretative amendment of the earlier entry. The later description limiting IV fluids to those used for sugar, electrolyte or fluid replenishment could not be read retrospectively into the earlier exemption. Technical literature and expert opinion showed that intravenous fluids remain IV fluids even when medicaments are added, provided they are sterile large-volume preparations and are administered intravenously. On that basis, the products of 100 ml or more which were cleared as IV fluids were held to fall within the exemption. Products of less than 100 ml, and goods used for peritoneal dialysis or irrigation, were not treated as IV fluids.
Conclusion: The exemption was allowable for the qualifying IV fluid products of 100 ml or more, but not for the smaller-volume or non-intravenous products.
Issue (ii): Whether duty demand, penalty and interest were sustainable in respect of the goods found outside the exempted category.
Analysis: Duty was upheld only for the goods that did not satisfy the IV fluid description. Since the dispute turned on interpretation of the exemption notifications and the relevant facts had been disclosed in the classification declarations, there was no suppression or misstatement warranting penalty. In such an interpretational dispute, penalty under Section 11AC and Rule 173Q was not justified, and interest under Section 11AB was also held not maintainable. Cum-duty benefit was directed to be available while recomputing duty.
Conclusion: Duty was sustained only for the non-qualifying goods, while penalty and interest were set aside.
Final Conclusion: The appeals succeeded in part by granting exemption to the qualifying intravenous fluid products, sustaining duty only on the excluded items, and disallowing penalty and interest.
Ratio Decidendi: A later exemption notification cannot retrospectively narrow the scope of an earlier exemption unless it is clearly an amending or clarificatory provision, and medicinal additives do not by themselves take a sterile large-volume preparation out of the category of intravenous fluids.
TaxTMI 
AI Drafter ✕
TaxTMI 
